Tislelizumab in Combination With Sitravatinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Clinical trial NCT04921358 · TERMINATED

Trial details

NCT number: NCT04921358
Sponsor: BeiGene
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer (NSCLC)

Start date: 2021-07-27
Primary completion: 2023-12-20
Enrollment: 377

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.